Kuros Biosciences Announces Publication of Supportive Osteoimmunology Data for MagnetOs Bone Graft
News 21.02.2023 Schlieren (Zurich), Switzerland, 21 February, 2023 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, today announced the publication of key scientific data on the efficacy of MagnetOs bone graft in two prestigious, peer-reviewed scientific journals. Joost de Bruijn, Chief Executive Officer of Kuros, said:...